NCT00001929View on ClinicalTrials.gov

Treatment of Parkinson's Disease With Eliprodil

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 1999

Study Completion Date

January 31, 2001

Conditions
Movement DisordersParkinson Disease
Interventions
DRUG

Eliprodil

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00001929 - Treatment of Parkinson's Disease With Eliprodil | Biotech Hunter | Biotech Hunter